Advanced Retatrutide research, engineered for precision.
A triple-agonist peptide pen activating GLP-1, GIP and glucagon receptors — engineered for advanced metabolic research. Trusted by UK researchers for consistent, third-party verified quality.
40mg
Per pen, 4×10mg doses
24-48h
Tracked UK delivery
2-8°C
Cold-chain storage
From
£145.00
Lab Verified
Independent purity & content testing
Cold-Chain Shipping
Insulated, temperature-controlled packaging
Discreet Packaging
Plain, tamper-evident, unmarked boxes
Fast UK Delivery
Royal Mail tracked, 24-48h dispatch
Retatrutide 40mg Pen
A triple-agonist peptide pen activating GLP-1, GIP and glucagon receptors — engineered for advanced metabolic research.
- Triple-agonist activity across GLP-1, GIP and glucagon receptors
- 40mg pen — supplied as 4 doses of 10mg
- Store in a refrigerator between 2°C and 8°C
- For subcutaneous research use only
A Triple-Pathway Approach
Retatrutide is studied for its simultaneous action on three key metabolic receptors.
GLP-1 Receptor
Appetite Regulation
Supports appetite suppression and slower gastric emptying.
GIP Receptor
Insulin Response
Supports insulin sensitivity and fat utilisation.
Glucagon Receptor
Energy Expenditure
Supports higher energy expenditure and fat oxidation.
Ready to start your research?
Secure checkout • tracked UK delivery • discreet packaging.